Skip to content

A double-blind, parallel-group comparative study examining the effectiveness of green tea-derived components for physical condition in winter

Study to verify the effect of green tea-derived components to physical condition - A double-blind, parallel-group comparative study examining the effectiveness of green tea-derived components for physical condition in winter

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043122
Enrollment
100
Registered
2021-02-05
Start date
2021-02-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

12 weeks, Placebo drink, once a day 12 weeks, Active drink, including green tea-derived components, once a day

Sponsors

Kao Corporation
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Healthy Subjects

Exclusion criteria

Exclusion criteria: -Those who may develop seasonal allergic symptoms such as pollinosis during the test period and may use medicines -Those who are currently suffering from chronic diseases and receiving drug treatment -Those who may show allergic symptoms to the test food or those who may show allergic symptoms to tea and the ingredients contained in tea (catechin, theanine, caffeine) -Those who are pregnant or may become pregnant -Those who have difficulty in participating in the study due to liver / kidney / heart disease, respiratory disorder, endocrine disorder, metabolic disorder, neuropathy, consciousness disorder, diabetes, and other diseases. -Those who consume excessive alcohol (more than 60g/d) -Those who are participating in other human tests -Those infected with SARS-COV-2 -Those who do not work daily (those who have night rotation work) -Other persons who are judged by the investigator to be inappropriate for this study

Design outcomes

Primary

MeasureTime frame
Number of events that reduce physical condition when taking continuously for 12 weeks

Secondary

MeasureTime frame
Each evaluation item using GHQ60 when taking continuously for 12 weeks

Countries

Japan

Contacts

Public ContactTatsuya Kusaura

Kao Corporation Health & Wellness Research

kusaura.tatsuya@kao.com03-5630-7441

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026